Allogene Therapeutics, Inc. (ALLO)

Allogene Therapeutics Revenue

Allogene Therapeutics had revenue of $4.64M in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $4.64M. That makes Allogene Therapeutics the 40,206th largest company in the world by revenue and 5,347th in the United States.

• Revenue (ttm): $4.64M
• Revenue Growth: n/a
• P/S Ratio: 92.33
• Revenue / Employee: $30,526
• Employees: 152
• Market Cap: 424.95M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	22.00K	-73.00K	-76.84%
Dec 31, 2023	95.00K	-61.00K	-39.10%
Dec 31, 2022	156.00K	-113.93M	-99.86%
Dec 31, 2021	114.09M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 12, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error